SELLAS Life Sciences Group Inc (NASDAQ: SLS) is 12.50% higher on its value in year-to-date trading and has touched a low of $0.51 and a high of $1.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SLS stock was last observed hovering at around $1.41 in the last trading session, with the day’s loss setting it -0.24%.
Currently trading at $1.17, the stock is 11.93% and 9.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.33 million and changing -17.02% at the moment leaves the stock -4.27% off its SMA200. SLS registered 130.81% gain for a year compared to 6-month loss of 0.00%. The firm has a 50-day simple moving average (SMA 50) of $1.0674 and a 200-day simple moving average (SMA200) of $1.22225.
The stock witnessed a 25.87% gain in the last 1 month and extending the period to 3 months gives it a 6.36%, and is 1.74% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 30.69% over the week and 14.13% over the month.
SELLAS Life Sciences Group Inc (SLS) has around 16 employees, a market worth around $82.35M and $0.00M in sales. Distance from 52-week low is 131.18% and -31.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-203.12%).
The EPS is expected to grow by 59.95% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
SELLAS Life Sciences Group Inc (SLS) Top Institutional Holders
35.0 institutions hold shares in SELLAS Life Sciences Group Inc (SLS), with institutional investors hold 7.38% of the company’s shares. The shares outstanding are 70.38M, and float is at 68.75M with Short Float at 13.09%. Institutions hold 7.36% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.79 million shares valued at $2.13 million. The investor’s holdings represent 3.9862% of the SLS Shares outstanding. As of 2024-06-30, the second largest holder is SUSQUEHANNA INTERNATIONAL GROUP, LLP with 1.64 million shares valued at $1.95 million to account for 3.6594 of the shares outstanding. The other top investors are ALYESKA INVESTMENT GROUP, L.P. which holds 1.48 million shares representing 3.3005% and valued at over $1.76 million, while GEODE CAPITAL MANAGEMENT, LLC holds 1.1537 of the shares totaling 0.52 million with a market value of $0.62 million.
SELLAS Life Sciences Group Inc (SLS) Insider Activity
#####
